Sarchi Christopher 4

What Happened
Christopher Sarchi, Chief Commercial Officer of Replimune Group (REPL), received two awards on April 1, 2026: 50,000 restricted stock units (RSUs) and a 75,000-share derivative award (total 125,000). Both awards were reported at $0.00 per share (no cash purchase). These are grants/awards (code A) rather than open-market purchases or sales.

Key Details

• Transaction date: April 1, 2026; reported price: $0.00 per share.
• Grant breakdown: 50,000 RSUs (F1) + 75,000 derivative award (F2) = 125,000 total shares potentially issuable.
• Vesting (per footnotes): F1 (50k RSUs) — 25% vest May 15, 2027; remaining vest in three roughly equal annual installments through May 15, 2030. F2 (75k derivative award/option-like) — 25% vest April 1, 2027; remaining vests in ~36 equal monthly installments thereafter.
• Shares owned after the transaction: Not specified in the provided filing details.
• Filing timeliness: This Form 4 was filed late due to an inadvertent administrative error (timeliness flag: L).

Context
RSUs and derivative awards are forms of compensation/retention: they do not involve an immediate cash outlay and typically convert to common stock only as they vest. This filing does not indicate any immediate sale of shares. The late filing is administrative; it does not change the economic nature of the grants but delays public disclosure of the award.